Company profile

KetoSwiss AG

Due to our modern carb rich diets our brains rely predominantly on glucose,which can contribute to an energy deficiency in the brain and trigger migraine. KetoSwiss(KS) has developed a novel migraine preventative. Its active compound is an endogenous metabolite; a ketone body(KB), which is used by the brain as an alternative fuel to glucose, when glucose utilization or transport is limited. KBs are produced by the liver during fasting/carb restriction but have a short half-life. KS strives to bring human identical KBs back into our modern world. The product is patent backed & superior to any current competition. We can achieve infusion-like therapeutic ketosis with a single neutral tasting oral dose. Reaching just 10% of the migraineur target group in US,EU,Ca & J can deliver 1.8b revenue.

More news about KetoSwiss AG

16.04.2024 10:12

KetoSwiss launches first medical food for migraine in the U.S.

Please login or
register to use the
awards follow feature
20.11.2023 08:29

Drei Unternehmerinnen mit POWHER Award ausgezeichnet

Please login or
register to use the
awards follow feature
30.10.2023 15:00

Recruitment heralds new phase for start-ups

Please login or
register to use the
awards follow feature
04.08.2023 15:47

Additional funds for KetoSwiss

Please login or
register to use the
awards follow feature
13.10.2022 11:30

KetoSwiss secures $4 million

Please login or
register to use the
awards follow feature
16.07.2021 15:05

KetoSwiss braces for US launch following its capital increase

Please login or
register to use the
awards follow feature
11.03.2021 13:40

New appointments at life sciences startups

Please login or
register to use the
awards follow feature
KetoSwiss AG

Founded
2017

Kanton
BS


LinkedIn

Homepage

rss